Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

The Relationship Between Serum Pentraxin 3 and Central Obesity in ST-Segment Elevation Myocardial Infarction Patients

  • Shim, Byung-Ju (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Jeon, Hui-Kyung (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Lee, Seung-Jae (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kim, Sung-Sik (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Park, Mi-Youn (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Lee, Dong-Hyeun (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Shin, Woo-Seung (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jong-Min (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Youn, Ho-Joong (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Chung, Wook-Sung (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Seung, Ki-Bae (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
  • Received : 2009.10.10
  • Accepted : 2010.01.12
  • Published : 2010.07.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: As shown in previous studies, pentraxin 3 (PTX3) can be a useful inflammatory marker for metabolic syndrome and central obesity. Serum PTX3 levels are also an independent factor associated with visceral fat area. The aim of this study was to assess the role of PTX3 as an inflammatory maker in patients with central obesity undergoing primary percutaneous coronary intervention (PCI) following an ST-segment elevation myocardial infarction (STEMI). Subjects and Methods: From December 2007 to June 2008, 40 subjects (mean age: 61${\pm}$11 years, M : F=34 : 6) with STEMI who underwent primary PCI were enrolled. We determined waist circumference, waist/hip ratio, body mass index (BMI), and visceral and total fat area via fat computed tomography (FAT-CT), and compared them with serum PTX3 concentrations. Results: The serum PTX3 concentration was closely related to FAT-CT-estimated visceral fat area (r=0.41, p<0.01) and total fat area (r=0.38, p=0.01), respectively. The serum PTX3 concentration was not related to waist circumference (r=0.27, p=0.20), waist circumference/hip ratio (r=0.25, p=0.16), BMI (r=0.04, p=0.80) and lipid profiles, respectively. Among the parameters determining metabolic syndrome, an increasing visceral fat area had the strongest association with PTX3 concentrations. Conclusion: In patients with STEMI, PTX3 is associated with central obesity and it is significantly and independently correlated with visceral fat area. FAT-CT-estimated visceral fat area is the most reliable factor associated with serum PTX3 levels in patients with STEMI and central obesity.

Keywords

References

  1. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41. https://doi.org/10.1038/35025203
  2. Noh HJ, Kwon NH, Joo SB. Severity of coronary atherosclerosis: influence of metabolic syndrome risk factor clustering and hs-CRP. Korean Circ J 2006;36:802-8. https://doi.org/10.4070/kcj.2006.36.12.802
  3. Rattazi M, Faggin E, Bertipaglia B, Pauletto P. Innate immunity and atherogenesis. Lupus 2005;14:747-51. https://doi.org/10.1191/0961203305lu2213oa
  4. Hansson GK, Robertson AL, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006;1:297-329. https://doi.org/10.1146/annurev.pathol.1.110304.100100
  5. Koo BK, Choi DH, Ryu SK, et al. Role of inflammation on coronary artery disease in Koreans. Korean Circ J 2002;32:988-95.
  6. Kim TI, Chae SC, Yang DH, Shin SC, et al. Short-term prognostic value of CRP in the patients with acute coronary syndrome. Korean Circ J 2000;30:1387-94.
  7. Mantovani A, Garlanda C, Bottazzi B. Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine 2003;21(Suppl 2):S43-7. https://doi.org/10.1016/S0264-410X(03)00199-3
  8. Mantovani A, Garlanda C, Bottazzi B, et al. The long pentraxin PTX3 in vascular pathology. Vascul Pharmacol 2006;45:326-30. https://doi.org/10.1016/j.vph.2006.08.011
  9. Napoleone E, Di Santo A, Bastone A, et al. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol 2002;22:782-7. https://doi.org/10.1161/01.ATV.0000012282.39306.64
  10. Peri G, Introna M, Corradi D, et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000;102:636-41. https://doi.org/10.1161/01.CIR.102.6.636
  11. Suzuki S, Takeishi Y, Niizeki T, et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J 2008;155:75-81. https://doi.org/10.1016/j.ahj.2007.08.013
  12. Moon DK, Lee DH, Youn HJ, et al. Pentraxin 3 as an inflammatory marker in subjects with metabolic syndrome. Korean J Med 2007;451S. Abstract.
  13. Alberti L, Gilardini L, Zulian A, et al. Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Atherosclerosis 2009;202:455-60. https://doi.org/10.1016/j.atherosclerosis.2008.05.015
  14. Kim JA, Choi CJ, Yum KS. Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population. J Korean Med Sci 2006;21:1048-53. https://doi.org/10.3346/jkms.2006.21.6.1048
  15. Zenetti M, Bosutti A, Ferreira C, et al. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. Clin Exp Med 2009;9:243-8. https://doi.org/10.1007/s10238-009-0039-z
  16. Latini R, Maggioni AP, Peri G, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004;110:2349-54. https://doi.org/10.1161/01.CIR.0000145167.30987.2E
  17. Introna M, Alles VV, Castellano M, et al. Cloning of mouse PTX3, a new marker of the pentraxin gene family expressed at extrahepatic sites. Blood 1996;87:1862-72.
  18. Presta M, Camozzi M, Salvatori G, Rusnati M. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007;11:723-38. https://doi.org/10.1111/j.1582-4934.2007.00061.x
  19. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-83. https://doi.org/10.1038/nri1937
  20. Takeno M, Yasuda S, Otsuka Y, et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarctionpotential association with C-reactive protein. Circ J 2008;72:415-9. https://doi.org/10.1253/circj.72.415
  21. Clavijo LC, Pinto TL, Kuchulakanti PK, et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Rrevasc Med 2006;7:7-11. https://doi.org/10.1016/j.carrev.2005.10.007
  22. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-9. https://doi.org/10.1016/S0140-6736(05)67663-5
  23. Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women. Circulation 2004;109:706-13. https://doi.org/10.1161/01.CIR.0000115514.44135.A8

Cited by

  1. Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease vol.6, pp.12, 2010, https://doi.org/10.2215/cjn.02320311
  2. Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity vol.301, pp.6, 2011, https://doi.org/10.1152/ajpendo.00163.2011
  3. Effects of Ecklonia cava Polyphenol in Individuals with Hypercholesterolemia: A Pilot Study vol.15, pp.11, 2012, https://doi.org/10.1089/jmf.2011.1996
  4. Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps vol.3, pp.None, 2012, https://doi.org/10.3389/fimmu.2012.00378